You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
|
---|---|
Published in |
Frontiers in oncology, June 2020
|
DOI | 10.3389/fonc.2020.01012 |
Pubmed ID | |
Authors |
Federico La Manna, Marta De Menna, Nikhil Patel, Sofia Karkampouna, Maria Rosaria De Filippo, Irena Klima, Peter Kloen, Lijkele Beimers, George N. Thalmann, Rob C. M. Pelger, Estela Jacinto, Marianna Kruithof-de Julio |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 4 | 29% |
United States | 2 | 14% |
United Kingdom | 1 | 7% |
Unknown | 7 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 7 | 50% |
Members of the public | 6 | 43% |
Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Lecturer | 5 | 14% |
Student > Bachelor | 4 | 11% |
Student > Ph. D. Student | 3 | 8% |
Researcher | 3 | 8% |
Student > Master | 3 | 8% |
Other | 5 | 14% |
Unknown | 13 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 9 | 25% |
Medicine and Dentistry | 4 | 11% |
Agricultural and Biological Sciences | 3 | 8% |
Nursing and Health Professions | 2 | 6% |
Computer Science | 2 | 6% |
Other | 1 | 3% |
Unknown | 15 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2020.
All research outputs
#4,917,540
of 26,205,030 outputs
Outputs from Frontiers in oncology
#1,706
of 22,934 outputs
Outputs of similar age
#115,677
of 437,389 outputs
Outputs of similar age from Frontiers in oncology
#52
of 501 outputs
Altmetric has tracked 26,205,030 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,934 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,389 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 501 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.